Quantcast

Latest Management of cancer Stories

2014-04-30 08:31:39

DUBLIN, Apr. 30, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/wzl2nj/tissue) has announced the addition of the "Tissue Diagnostics Market by Technology, Disease, Product, End-Users & Region - Trends & Forecast to 2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Tissue diagnostics is used to determine the stage, prognosis, and treatment course of cancer. According to estimates by the International Agency for...

2014-04-28 23:09:34

Austin-based tech company, Photetica, is now in the clinical trial phase with its newest medical device, Lazarus, and has launched a crowdfunding campaign through Indiegogo to support clinical studies. Austin, TX (PRWEB) April 28, 2014 Lazarus, the patented medical technology designed to prevent and reverse chemotherapy side effects during breast cancer treatment, today announced their global launch to secure funds for clinical trials through Indiegogo. Photetica has been working on...

2014-04-28 08:31:47

HACKENSACK, N.J., April 28, 2014 /PRNewswire/ -- Results from a study published in Clinical Cancer Research demonstrate that oncologists were able to accurately predict which therapies patients would respond to by using a combination of next-generation sequencing and drug sensitivity testing in mouse avatars (Champions TumorGrafts®) developed by Champions Oncology (OTC: CSBR). The paper, titled "Integrated Next Generation Sequencing and Avatar Mouse Models for Personalized Cancer...

2014-04-25 12:26:33

DUBLIN, Apr. 25, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/dj4r99/global_testicular) has announced the addition of the "Global Testicular Cancer Drugs Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The current trend witnessed by the Global Testicular Cancer Drugs market is combination therapy being used for treating testicular cancer. Several oncologists believe that chemotherapy drugs are most...

2014-04-25 08:25:47

Dr. Moromisato's "A Theory of Fairness" Concludes Only Higher Taxes on the Very Rich May Staunch Growth of the Debilitating Malignancy DENVER, April 25, 2014 /PRNewswire/ -- A new book by Dr. J. H. Moromisato, Director of the Reformed Economics Institute at Denver, CO, describes a novel approach to taxation, which finds current taxation utterly regressive against 99.5% of taxpayers, and greatly beneficial to the privileged 0.5% at the top of the income distribution. Photo -...

2014-04-23 23:10:18

According to a new Korean study, a new method of diagnosing bladder cancer could “augment or replace” current approaches. Raleigh, NC (PRWEB) April 23, 2014 Cancer researchers in Korea say they have developed a simpler and less invasive way to diagnose bladder cancer from a urine sample. Details of the new study have just been posted on the Cancer Monthly website. Click here to learn more. Scientists with the Natural Product Research Institute at Seoul National University have...

2014-04-23 23:04:55

GIA announces the release of a comprehensive global report on Brachytherapy markets. Global market for Brachytherapy Devices is projected to reach US$411 million by 2020, driven by rising cancer cases, aging population, and growing need for more effective therapeutics. San Jose, California (PRWEB) April 23, 2014 Follow us on LinkedIn - Cancer has emerged as one of the most critical health issues worldwide. Rising incidence of cancer and growing medical awareness continues to increase the...

2014-04-22 08:33:31

Company to Report On Science And Progress Of DCVax-Direct Trial At World's Largest Cancer Conference BETHESDA, Md., April 22, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that ASCO (the American Society for Clinical Oncology) has announced in its Annual Meeting program that the Company will present its DCVax-Direct clinical trial and technology...

2014-04-22 08:33:21

Expanded Reimbursement in Canada and Inclusion in Leading German Physician Guidelines Increase Genomic Health's Impact in Key International Markets REDWOOD CITY, Calif., April 22, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced two important international milestones including additional reimbursement in Canada and the inclusion of the Oncotype DX(®) breast cancer test in major German clinical guidelines. In Canada, the BC Cancer Agency in British Columbia...

Researchers Discover Biomarker Leading To Cancer Drug Resistance
2014-04-21 07:52:12

redOrbit staff & Wire Reports – Your Universe Online Researchers from the University of California, San Diego School of Medicine have located a biomarker that they believe could help explain why many of the medications used to treat lung, breast and pancreatic cancers also promote drug resistance and ultimately cause tumors to form in patients. Writing in the April 20 online edition of Nature Cell Biology, the study authors report the discovery of a molecule known as CD61 that is...


Word of the Day
caparison
  • A cloth or covering, more or less ornamented, laid over the saddle or furniture of a horse, especially of a sumpter-horse or horse of state.
  • Clothing, especially sumptuous clothing; equipment; outfit.
  • To cover with a caparison, as a horse.
  • To dress sumptuously; adorn with rich dress.
This word ultimately comes from the Medieval Latin 'cappa,' cloak.
Related